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A binding site for the channel-blocking noncompetitive antagonist [3H]triphenylmethylphosphonium 
([3H]TPMP’) was localized in the cc-, /I- and b-chains of the nicotinic acetylcholine receptor (AChR) from 
Torpedo marmorata electric tissue. The photolabel was found in homologous positions of the highly con- 
served sequence helix II, tl 248,j 254, and 6 262. The site of the photoreaction appears to not be affected 
by the functional state of the receptor. [3H]TPMP+ was found in position 6 262 independent of whether 
photolabeling was performed with the receptor in its resting, desensitized or antagonist state. A model of 
the AChR ion channel is proposed, according to which the channel is formed by the five helices II contrib- 
uted by the five receptor subunits. 
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1. INTRODUCTION 
The nicotinic acetylcholine receptor (AChR) is a 
pentameric glycoprotein with the subunit composi- 
tion ~$3~8. The primary structures of the polypep- 
tide chains have been deduced from the precursor- 
cDNA sequences and various structural models of 
the protein complex in its membrane environment 
and of the ion channel formed by the receptor pro- 
tein have been proposed (review [l]). The binding 
sites for agonists and competitive antagonists are 
located on the a-subunits, probably around posi- 
tion 192/193 of the primary structure [2,3]. The 
location and structure of the ion channel are 
unknown. Noncompetitive antagonists, a very 
heterogenous group of compounds, are thought to 
be tools for its elucidation because they block ion 
fluxes by sterically or allosterically interacting with 
the channel [4]. Recently a binding site for the non- 
competitive antagonists chlorpromazine [5] and 
TPMP+ [6] has been localized in the S-subunit of 
AChR from Torpedo marmorata by photoaffinity 
labeling and microsequencing work. It was iden- 
tified as serine 262 located in the membrane- 
spanning helix II (according to the five-helix model 
proposed by Finer-Moore and Stroud [7] and Guy 
[S]). Here we present evidence that our non- 
competitive antagonist, [3H]TPMP+, reacts upon 
photoactivation with homologous sequences in (Y- 
and P-chains as well suggesting that the ion chan- 
nel is formed by the hydrophobic helix II of each 
of the receptor subunits. We propose a channel 
model on the basis of this finding. 
2. MATERIALS AND METHODS 
2.1. Photoaffinity labeling 
Photoaffinity labeling of the membrane-bound 
receptor was performed with receptor-rich mem- 
branes prepared from T. marmorata electric tissue 
[9] as described [lo]. All photoaffinity labeling ex- 
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periments with the noncompetitive antagonist 
[3H]TPMP + were performed in the absence of any 
other cholinergic effector, agonist or antagonist. 
Specificity of the labeling was proven by 
histrionicotoxin (HTX) which prevented labeling 
completely [6]. 
2.2. Purification of rH]TPMP+ -labeled subunits 
The procedure was essentially as described 
before [6]. The photolabeled receptor-rich mem- 
branes were dissolved in sample buffer and the 
polypeptide chains were separated in two steps by 
preparative SDS-polyacrylamide gel elec- 
trophoresis, using the apparatus from BRL, 
Bethesda. In the first run the upper gel was 3% and 
the lower gel was 7.5% [ll]. About 4 mg protein 
were applied. Electrophoresis was performed at 6 
mA/l50 V. The elution buffer contained 0.1% 
SDS in 0.576 M glycine and 0.075 M Tris-HCl, pH 
8.3. Elution rate was 15 ml/h. 
Purity of the chains in the fractions was assessed 
by analytical SDS-polyacrylamide gel elec- 
trophoresis. Fractions containing predominantly 6- 
chains were pooled and reelectrophoresed after 
dialysis against water and lyophilization as above, 
but on 10% gel. 
2.3. CNBr cleavage 
CNBr cleavage of the labeled subunits was per- 
formed after lyophilization and reduction with ,&- 
mercaptoethanol according to Gross and Witkop 
1121. 
2.4. Tryptic digestion 
Tryptic digestion was performed for 5-20 h with 
3-10070 TPCK-trypsin at a protein concentration of 
15 pg/ml. 
2.5. Reversed-phase chromatography (HPLC) 
Separation was performed on a pre-packed steel 
column (Knauer, Berlin), 250 x 4.0 mm i.d., filled 
with Organogen HP-Gel-RP-7, pore size 300 A, 
particle size 7 pm. Proteins were eluted at 60°C 
with gradients from buffer A (0.1% trifluoroacetic 
acid, TFA, in water) and buffer B (0.03% TFA in 
2-propanol/acetonitrile, 70 : 30). 
2.6. Microsequencing 
Microsequencing was performed in a gas-phase 
sequenator from Applied Biosystems (model 470 
138 
A). l/3 of each PTH-amino acid fraction was used 
for determining the radioactivity by liquid scin- 
tillation counting. 
3. RESULTS 
Fig.la-c shows the HPLC chromatogramms of 
tryptic digests of the [3H]TPMP+-labeled a-, ,& 
and S-chains, respectively. The UV absorption pat- 
terns are fairly different, as one would expect con- 
sidering the differences in size and sequence of 
these subunits. The distribution of radioactivity on 
the other hand is surprisingly similar. Three peaks 
of low radioactivity are followed by a broad peak 
containing the vast majority of the label. 
Microsequencing of the center fractions of the 
latter released in each case radioactivity exclusively 
in the sixth Edman-degradation step (fig.2). This 
indicates that the label is located six amino acids 
downstream from a lysine or arginine, the tryptic 
cleavage sites. Treatment of the same peptide with 
cyanogen bromide and subsequent microsequenc- 
ing yielded the radioactivity in the fifth Edman cy- 
cle, indicating that the label is located five amino 
acids downstream from a methionine. Both ex- 
periments together prove that labeling occurred in 
a sequence starting with Lys (or Arg) Met. This se- 
quence occurs only once at position 263/264 
(numbering of the aligned sequences). In the 
primary structure of receptor from T. californica 
six, respectively five amino acids downstream is 
located a serine residue (Ser 262 in S, Ser 254 in fl, 
and Ser 248 in LY). Very little radioactive label was 
incorporated into the y-chain and therefore could 
not be localized by the method described. The cor- 
responding position in this chain is Ser 257. 
The peptide fractions used for microsequencing 
were not pure. The amino acids identified by Ed- 
man degradation indicated a mixture of sequences. 
The sequence of the tryptic peptide T 21 (and the 
CNBr peptide CB 5) were clearly identified among 
others. The localization through the radioactive 
PTH-amino acid was unequivocal. 
The conclusion from these experiments is that 
the noncompetitive blocker [3H]TPMP+ binds to 
a site near the helix II of at least three of the five 
polypeptide chains of the receptor and upon ir- 
radiation with UV light it reacts covalently with 
serine residues in homologous positions within this 
helix. 
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Fig. 1. Purification of peptides obtained by tryptic diges- 
tion of [3H]TPMP + -labeled subunits of acetylcholine 
receptor. (a) a-Subunit, (b) &subunit, (c) S-subunit. 
Solid line, UV-absorption; bars, radioactivity in 50 pl 
aliquots of 1 ml fractions. Elution profiles are different 
for the different subunits but radioactivity distribution is 
similar indicating that homologous regions are labeled 
by ['H]TPMP' . Column, HP-Gel-RP-7 (Knauer, 
Berlin), pore size 300 A, particle size 7 pm, column 
dimensions 250 x 4.00 mm. Elution buffer A, 0.1% 
aqueous TFA; buffer B, 0.03% TFA in 2-propanol/ 
acetonitrile (70: 30); gradient, from 20% B to 80% B in 
60 min. Absorbance measured at 230 nm. Photoaffinity 
labeling of membrane-bound acetylcholine receptor 
from T. marmorafa electric tissue was performed with 
[‘H]TPMP + without agonist or competitive antagonist, 
according to [lo]. Separation of labeled subunit from 
the receptor complex by preparative SDS-polyacryl- 
amide gel electrophoresis was described before [6]. Tryp- 
tic digestion was performed by incubating the separated 
subunits with 10% (w/w) TPCK-trypsin (Worthington) 
for 24 h. The hydrolysate was concentrated in a vacuum 
concentrator in the presence of 1 mM dithioerythritol 
(Merck). Precipitated protein was redissolved by adding 
90% formic acid. This solution was subjected to HPLC 
chromatography. 
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Fig.2. Localization of the [3H]TPMP + -labeled position 
in the primary structure by microsequencing. The main 
radioactive fractions of the tryptic hydrolysate (reten- 
tion time 47-51 min, fig. 1) obtained from the (Y-, ,& and 
S-subunits (a,b,c, respectively) were automatically 
microsequenced in a gas-phase sequenator (Applied 
Biosystems model 470A). The phenylthiohydantoin 
(PTH) amino acids were identified on an isocratic recy- 
cling HPLC. Aliquots of the PTH amino acids were 
removed for determination of radioactivity. Maximum 
radioactivity was always found in step 6. Treatment of 
the peptide fraction with CNBr before microsequencing 
shifted radioactivity to the fifth Edman-degradation cy- 
cle (dashed line in c). 
The primary structure of receptor from T. mar- 
morata is known only for the a-chain [ 131. For the 
other chains we only postulate the serine in this 
position. Because of its modification by 
[3H]TPMP + we are not able to identify the amino 
acid; there appear to be very few exchanges be- 
tween the receptors from the two species, even 
fewer appear to occur in the highly conserved helix 
II. 
This result is obtained irrespective of the func- 
tional state of the receptor protein: Labeling in this 
presence of agonist, i.e. with the receptor in its 
desensitized state, causes preferential labeling of 
the S-subunit and to a lesser degree of ,d; labeling 
in the absence of effector (i.e. with the receptor in 
its resting state) causes incorporation of radioac- 
tivity into the LY-, ,& and S-polypeptide chains. 
Even on photolabeling in the presence of an an- 
tagonist which was shown to cause a conforma- 
tional change in the receptor protein as well [14], 
a similar pattern of radioactivity in the HPLC 
chromatogram was obtained (not shown). The 
conformational changes appear to affect the yield 
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of the photolabeling but not the site in the 
sequence. 
We have not shown that homologous sites in the 
y-chain and in both a-chains (which have identical 
sequences but are not functionally equivalent 
[ 15,161) are photolabeled by the noncompetitive 
antagonist. Nevertheless based on positive 
evidence for three of the five subunits and on the 
results from electron microscopy which had shown 
that the ion channel has a 5-fold axis of symmetry 
[ 171, we propose a model of the channel (fig.3) ac- 
cording to which it is formed by the five 
homologous helices II contributed from the five 
receptor subunits. 
Cytoskeleto6 -“, (43 k) 
Fig.3. Model of the nicotinic acetylcholine receptor and its ion channel. (A) Section through the receptor complex 
perpendicular to the membrane plane. Extracellular space: top. About 50% of the receptor protrudes from the outer 
surface, 30-35% is immersed in the lipid bilayer. The five polypeptide chains (one of the two a-chains is removed) span 
the membrane with each five hydrophobic helices, the amino terminus being located extracellularly, the carboxy ter- 
minus intracellularly. The entrance of the ion channel is depicted large enough to let hydrated cations and the channel 
blocker [3H]TPMP+ into a site close to the inner surface. The ion channel is formed by each one of the five membrane- 
spanning helices contributed by the receptor subunits. The proposed helices comprise amino acids 260-287 of the aligned 
sequences [I]. The site of covalent attachment of [3H]TPMP+ is in position 269 in the aligned sequences (or position 
262, 254, and 248 in (Y, p and 6, respectively. Note that the five helices in this model are parallel, with the N-terminal 
end (and thereby the positive pole of the helix-dipole) oriented towards the cytoplasm. The carbohydrate residues (zig- 
zag lines on top), as well as sialic acids (negative charges), Ca’+, phosphate groups, cytoskeleton and 43 kDa protein 
are neither drawn to scale nor do they represent he correct stoichiometry. (B) Cross-section through the receptor com- 
plex in the membrane plane. Depicted are the membrane-spanning helices (shaded circles and open circles representing 
helix II). The helices II (according to the numbering of Finer-Moore and Stroud, [7]) form the wall of the ion channel, 
giving it its 5-fold symmetry axis. The other helices are arranged arbitrarily. Each five helices (circles) represent one 
of the five receptor subunits. 
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4. DISCUSSION 
[3H]TPMP reacts after photoactivation with 
homologous positions in the primary structures of 
the cy-, p- and S-polypeptide chains. This indicates 
that it is bound in the center of the receptor com- 
plex, from where covalent reaction with either of 
the subunits is possible. It is tempting to assume 
that the central [3H]TPMP + -binding site 
represents a part of the ion channel. Evidence in 
favor of this assumption is provided by the follow- 
ing observations: [3H]TPMP + binds reversibly 
with high affinity and noncompetitively with 
respect to acetylcholine; there is only one high- 
affinity binding site for [3H]TPMP+ for each two 
acetylcholine-binding sites of the membrane- 
bound receptor [ 181. Proven channel blockers such 
as HTX or phencyclidine compete with 
[3H]TPMP + for a common binding site; HTX 
prevents photolabeling of AChR with 
[3H]TPMP + [6,18]. [3H]TPMP + inhibits AChR- 
regulated cation flux [18] and has been shown to 
block neuromuscular transmission in a voltage- 
dependent manner [ 19,201. In single channel 
analysis it shortens the channel lifetime [19]. 
On the other hand, TPMP+ has all the 
characteristics of an allosteric effector: its binding 
site is affected allosterically by agonists [ 10,181 and 
it enhances desensitization [19]. It binds to AChR 
in its resting or desensitized state, indicating that 
channel activation is not necessary for binding and 
that the binding site is probably not located within 
the open channel. 
The model proposed in fig.3 takes these observa- 
tions into account. The photolabel [3H]TPMP + 
has a larger diameter [21] than the largest cations 
able to permeate through the channel (6.4 A ac- 
cording to [22]). It may therefore bind to a wider 
part of the channel entrance where it may block it 
sterically and allosterically at the same time. At 
this site it may not even sense whether or not the 
channel is open. This would explain why the same 
site is labeled (though to a different extent) when 
photolabeling is performed in the presence or 
absence of cholinergic effecters. 
We postulate that the ion channel of the AChR 
is lined by helix II, predicted to be one of five 
membrane-spanning helices [7,8]. The five helices 
II (each one from the five receptor subunits ac- 
cording to this model) contribute to the architec- 
ture of a membrane-spanning, cation-selective, 
agonist gated pore. This does not preclude that 
other parts of the receptor protein not being la- 
beled by [3H]TPMP+ are involved as well. Com- 
paring the known sequences of AChR subunits 
from a variety of organisms it is obvious that helix 
II is the best conserved [21], much better conserved 
than the amphipathic helix MA predicted by others 
[7] to form the channel. 
Helix II may look at first sight too hydrophobic 
to form a water-filled pore [23] transporting 
charged particles. But we would like to point out 
that it is hydrophobic only in the upper part where 
the pore appears wide enough to let the large 
photolabel enter. From the reaction site on the 
photolabel (Ser 262 in S) several polar residues oc- 
cur in all subunits. Since [3H]TPMP + does not 
enter this part of the pore it might be too narrow, 
and it might form the selectivity filter of the ion 
channel. 
Gramicidin and even more so alamethicin may 
be seen as examples of channels formed by pep- 
tides without charged side chains. Charges within 
a channel would pose problems because strong 
ionic interactions would inhibit ion flux, especially 
in a domain contributing to the selectivity filter. At 
the wide channel entrance charges may be located 
much more favourably. There they would attract 
and concentrate ions as has been shown with a 
pyromellit-derivatized gramicidin channel [24]. 
Note that charged amino acids are located at the 
start of helix II. 
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